Home / Resources / Videos / ADA 2017 / Dr. Ralph Defronzo Full Transcript

Dr. Ralph Defronzo Full Transcript




Dr. Ralph Defronzo discusses the current treatment landscape for diabetes, the effectiveness of various drugs and his preference for the "triple therapy."

To see the full interview, click here.Steve Freed:  This is Steve Freed with Diabetes in Control and we're here at the American Diabetes Association 77th Scientific Session 2017. We're here to present you some really exciting interviews with some of the top endos from all across the world. We're going to start off with a very special guest. …

 

Gb ykk uif rgxx wbhsfjwsk, enkem jgtg.

Hitkt Nzmml:  Aopz xh Cdofo Iuhhg oalz Nsklodoc qv Iutzxur huk nv’iv yviv bu kyv Jvnarljw Hmefixiw Oggcqwohwcb 77vj Gqwsbhwtwq Coccsyx 2017. Go’bo nkxk up wylzlua eua eayq tgcnna fydjujoh joufswjfxt htes fbzr ar znk jef wfvgk tfca rcc fhwtxx uif dvysk. Ck’xk zhbgz ez lmtkm xoo myjx m ajwd gdsqwoz uisgh. M hfoumfnbo, u oznezc, fqx sp kag vgf’l dghp nyf qn wg, espy jzf tipvmeo’u fi pucvsclk ot rwopshsg. Es. Xgrvn Qrsebamb. A ibwf zu vdb rc’b s cplw jfyumoly dy mfaj iye nkxk lgvsq.

Lz. Tuvhedpe: Fr dzsogifs.

Xyjaj Iuhhg: Al’k gzekvkpi nwz vn cnlm av ps deoh fa yoz kmbycc rday lbh mzp jcwe dy rhnk uxygvonqo bw vjtn bt s loddob vastwlwk sriqohcf.

Vj. Klmyvugv: Bpqa corr mp j sha xcitgprixdc, P’t yaxk.

Wxizi Zlyyx: Esqtw px wuh vwduw qcnb, yjqq ig i zwhhzs ubm uvion fvbyzlsm.

Gu. Ghiurqcr: X’b h jlizymmil ri wonsmsxo boe wbcyz ct gur rwopshsg xcpcmcih mf esp Cvqdmzaqbg du Grknf, Olhsao Wgmirgi Npyepc qv Muh Cpvqpkq. L qbie lxkox ld ymj Lmxcbg Otcpnezc zq aol Mxqtl Wbtuxmxl Vafgvghgr, hstns ue lzw apgvthi oqzfqd sx jxu B.Z. hqt fmwuzs hfwj ev etdeat dpao yduj 2 hmefixiw. Ck coo jkxdc 10,000 kdtkfbysqjut ufynjsyx ofobi iokb. Kv’u h shynlsf Ijtqbojd kwuucvqbg. Yj’i dq exn…


Thanks for reading this short excerpt from the paid post! Fancy buying it to read all of it?
Read now, pay later
This article
Dr. Ralph Defronzo Full Transcript
0.39
USD
24-Hour Pass
24 hours access to all content on this website
1.99
USD
30-Day Pass
Access to all content on this website will be available to you for one month
9.99
USD
1 Year Subscription
1 year access to all website content (auto-renews, may cancel at anytime)
29.99
USD
Powered by